TUESDAY, June 7, 2022 (HealthDay News) — Reacting to the nation’s opioid epidemic, doctors in the United States are co-prescribing fewer opioid painkillers and benzodiazepines such as Ativan and Xanax, federal health officials report. When these drugs are taken together, the odds of an overdose, even a fatal overdose, increaseContinue Reading
Veterans at higher risk for deadly melanomas. They’re also more likely to present with advanced disease, so researchers encourage physicians to screen veterans as high-risk patients. Read more Can medical marijuana and CBD ease chronic pain? Despite a surge in acceptance and use, a new analysis finds little good evidenceContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — There’s more good news for coffee lovers who already reap its other health benefits — your favorite beverage may also help protect your kidneys. “We already know that drinking coffee on a regular basis has been associated with the prevention of chronic andContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — American farmers are at increased risk for tick bites, but new research shows they are doing little to defend themselves against the insects and the illnesses they cause. Tick-borne diseases include Lyme disease, Rocky Mountain Spotted fever, Powassan virus, anaplasmosis, tularemia, ehrlichiosis, heartlandContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — Open-source automated insulin delivery (AID) systems are an effective and safe way for people with type 1 diabetes to control their blood sugar levels, researchers say. The AID systems combine an insulin pump, a continuous glucose monitor (CGM), and an algorithm that automaticallyContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — High-tech devices and communication helped ease the impact of COVID-19 lockdowns on children with type 1 diabetes, researchers said in a new study. Pandemic shutdowns caused significant disruptions in health care, and previous studies have shown that diabetes patients had worse blood sugarContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Obesity is a well-known risk factor for type 2 diabetes. Now, a large new study adds to evidence that it also contributes to the much less common type 1 diabetes. The study, of nearly 1.5 million Israeli teenagers, found that those who wereContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Patients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease. Now, a new investigation may have landed on a surprising solution — a dummy pill that contains noContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be asContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimabContinue Reading